Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Liabilities and Shareholders Equity came in at $3.0 billion in Q1 2026, up 23.73% year-on-year from $2.4 billion in Q1 2025, and up 2.15% on a QoQ basis from $3.0 billion in Q4 2025.
Stevanato Group S.p.A (STVN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $3.0 billion in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 23.73% year-over-year to $3.0 billion in Q1 2026; TTM through Mar 2026 was $11.5 billion, a 17.88% increase from a year earlier, with the FY2025 full-year figure at $3.0 billion, up 19.0% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $3.0 billion, up from $3.0 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for STVN reached as high as $3.0 billion in Q1 2026 and fell as low as $1.6 billion in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $2.3 billion across 5 years, with a median of $2.4 billion in 2024.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 35.31% in 2022 and fell as far as 0.38% in 2022.
- Year by year, Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then surged by 31.63% to $2.2 billion in 2023, then rose by 11.65% to $2.5 billion in 2024, then gained by 19.0% to $3.0 billion in 2025, then gained by 2.15% to $3.0 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $3.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $2.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 3.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Mar 31, 2025 | 2.44 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.43 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 2.40 Bn |
| Dec 31, 2023 | 2.23 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 1.97 Bn |
| Mar 31, 2023 | 1.87 Bn |
| Dec 31, 2022 | 1.69 Bn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 1.64 Bn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.64 Bn |
| Jun 30, 2021 | 1.21 Bn |